MXRA7: A Potential Drug Target and Biomarker (G439921)

Target Name: MXRA7

NCBI ID: G439921

MXRA7

MXRA7: A Potential Drug Target and Biomarker

MXRA7, a protein found in the brain, has been identified as a potential drug target and biomarker for various neurological and psychiatric disorders. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research on its potential uses.

The discovery and characterization of MXRA7

MXRA7 was first identified as a protein that is expressed in the brain and is involved in the regulation of synaptic plasticity. Its function was further confirmed through experiments that demonstrated its ability to modulate the activity of neurons, which is critical for the formation and maintenance of neural connections.

MXRA7 is a member of the protein superfamily G-protein-coupled receptor (GPCR), which is a family of transmembrane proteins that play a central role in cellular signaling. GPCR proteins are involved in a wide range of physiological processes, including sensory perception, neurotransmission, and behavior.

MXRA7 functions as a GPCR

MXRA7 functions as a GPCR by interacting with G protein-coupled receptors (GPCRs) on the surface of neurons. GPCRs are involved in transmitting signals from the cell surface to the inside of the cell, and MXRA7 is thought to play a role in modulating the activity of these receptors.

Studies have shown that MXRA7 can interact with several different GPCRs, including GPCR伪2, GPCR尾2, and GPCR纬2. These interactions may be important for the regulation of synaptic plasticity, as MXRA7 is known to be involved in the formation and maintenance of neural connections.

MXRA7 as a drug target

MXRA7 has been identified as a potential drug target due to its involvement in the regulation of synaptic plasticity and its ability to modulate the activity of GPCRs. Drugs that can modulate the activity of MXRA7 or its interactions with GPCRs may be effective in treating a wide range of neurological and psychiatric disorders.

One approach to targeting MXRA7 is to use small molecules that can modulate its activity. Several studies have shown that inhibitors of MXRA7 can reduce the activity of GPCRs, including GPCR伪2 and GPCR尾2. This suggests that MXRA7 may be involved in the regulation of the activity of these receptors, and that inhibitors of MXRA7 may be effective in treating disorders related to GPCR function.

Another approach to targeting MXRA7 is to use antibodies that can specifically recognize and modulate its activity. Several studies have shown that antibodies against MXRA7 can reduce the activity of GPCRs, including GPCR伪2 and GPCR尾2. This suggests that MXRA7 may be involved in the regulation of the activity of these receptors, and that antibodies against MXRA7 may be effective in treating disorders related to GPCR function.

MXRA7 as a biomarker

MXRA7 may also be used as a biomarker for various neurological and psychiatric disorders. Its involvement in the regulation of synaptic plasticity and its ability to modulate the activity of GPCRs make it an attractive target for diagnostic tests.

One approach to using MXRA7 as a biomarker is to use techniques such as Western blotting or immunofluorescence to detect the protein in brain tissue or fluids. This can be used to confirm the presence of MXRA7 and to monitor changes in its levels over time.

MXRA7 has also been shown to be involved in the regulation of neural circuitry, which may be

Protein Name: Matrix Remodeling Associated 7

The "MXRA7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MXRA7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets